Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Broad Spectrum Protein Kinase Inhibitors
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 1227 | Apigenin |
| Protein kinase inhibitor | |
| 0542 | H-7 dihydrochloride |
| Protein kinase inhibitor | |
| 0396 | H-9 dihydrochloride |
| Protein kinase inhibitor | |
| 1520 | Hypericin |
| Inhibits tyrosine kinases | |
| 1813 | Indirubin-3'-oxime |
| Protein kinase inhibitor | |
| 1745 | 5-Iodotubercidin |
| Broad spectrum kinase inhibitor. Also nucleoside transporter inhibitor | |
| 1683 | K 252a |
| Protein kinase inhibitor | |
| 2992 | PKC 412 |
| Broad spectrum protein kinase inhibitor | |
| 2002 | Ro 31-8220 mesylate |
| Protein kinase inhibitor | |
| 1285 | Staurosporine |
| Non-selective protein kinase inhibitor | |
Substrates |
|
Cat.No. |
Product Name / Activity |
| 1155 | RR-src |
| Tyrosine kinase substrate peptide | |
Quick Order
Find multiple products by catalog number
Cancer Research Guide
Request your free copy
Highlights over 350 products for cancer research. Request a copy or view PDF today.
Kinases Product Listing
Highlights over 350 products for kinase research. Request a copy or view PDF today.
Kinase Inhibitor Toolbox
80 Kinase inhibitors
pre-dissolved in DMSO
Some of the most potent
kinase inhibitors all on one plate
Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.